Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Expression of CD40 Ligand in CD40-positive Murine Tumors Activates Transcription of the Interleukin-23 Subunit Genes and Produces Antitumor Responses

AKIHIKO WADA, YUJI TADA, OSAMU SHIMOZATO, YUICHI TAKIGUCHI, KOICHIRO TATSUMI, TAKAYUKI KURIYAMA and MASATOSHI TAGAWA
Anticancer Research September 2004, 24 (5A) 2713-2716;
AKIHIKO WADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJI TADA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
OSAMU SHIMOZATO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUICHI TAKIGUCHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOICHIRO TATSUMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKAYUKI KURIYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASATOSHI TAGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 24 no. 5A 2713-2716
PMID 
15517876

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 24, 2004
  • Accepted July 13, 2004
  • Published online September 1, 2004.

Copyright & Usage 
Copyright© 2004 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. AKIHIKO WADA1,2,
  2. YUJI TADA1,2,
  3. OSAMU SHIMOZATO1,
  4. YUICHI TAKIGUCHI2,
  5. KOICHIRO TATSUMI2,
  6. TAKAYUKI KURIYAMA2 and
  7. MASATOSHI TAGAWA1
  1. 1Division of Pathology, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba 260-8717
  2. 2Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba, 260-8670, Japan
  1. Correspondence to: Dr. Masatoshi Tagawa, Division of Pathology, Chiba Cancer Center Research Institute, 666-2 Nitona, Chuo-ku, Chiba 260-8717 Japan. Tel: +81-43-264-5431 ext.5101, Fax: +81-43-265-4459, e-mail: mtagawa{at}chiba-ccri.chuo.chiba.jp

Statistics from Altmetric.com

Cited By...

  • 5 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 24, Issue 5A
September-October 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Expression of CD40 Ligand in CD40-positive Murine Tumors Activates Transcription of the Interleukin-23 Subunit Genes and Produces Antitumor Responses
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Expression of CD40 Ligand in CD40-positive Murine Tumors Activates Transcription of the Interleukin-23 Subunit Genes and Produces Antitumor Responses
AKIHIKO WADA, YUJI TADA, OSAMU SHIMOZATO, YUICHI TAKIGUCHI, KOICHIRO TATSUMI, TAKAYUKI KURIYAMA, MASATOSHI TAGAWA
Anticancer Research Sep 2004, 24 (5A) 2713-2716;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Expression of CD40 Ligand in CD40-positive Murine Tumors Activates Transcription of the Interleukin-23 Subunit Genes and Produces Antitumor Responses
AKIHIKO WADA, YUJI TADA, OSAMU SHIMOZATO, YUICHI TAKIGUCHI, KOICHIRO TATSUMI, TAKAYUKI KURIYAMA, MASATOSHI TAGAWA
Anticancer Research Sep 2004, 24 (5A) 2713-2716;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis
  • Google Scholar

More in this TOC Section

  • CD133+ Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense
  • Iodine-Hoechst Enhances X-ray Sensitivity of Cancer Cells Under Normal and Low Oxygen Conditions
  • Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire